Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The multifaceted functions of C/EBPα in normal and malignant hematopoiesis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndrome

    Research output: Contribution to journalLetterResearchpeer-review

  4. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Quantitative single-cell proteomics as a tool to characterize cellular hierarchies

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Basement membrane stiffness determines metastases formation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The process of blood formation, hematopoiesis, depends upon a small number of hematopoietic stem cells (HSCs) that reside in the bone marrow (BM). Differentiation of HSCs is characterised by decreased expression of genes associated with self-renewal accompanied by a stepwise activation of genes promoting differentiation. Lineage branching is further directed by groups of cooperating and counteracting genes forming complex networks of lineage specific transcription factors. Imbalances in such networks can result in blockage of differentiation, lineage reprogramming and malignant transformation. CCAAT/Enhancer Binding Protein Alpha (C/EBPα) was originally identified 30 years ago as a transcription factor that binds both promoter and enhancer regions. Most of the early work focused on the role of C/EBPα in regulating transcriptional processes as well as on its functions in key differentiation processes during liver, adipogenic and hematopoietic development. Specifically, C/EBPα was shown to control differentiation by its ability to coordinate transcriptional output with cell cycle progression. Later, its role as an important tumour suppressor, mainly in acute myeloid leukaemia (AML), was recognised and has been the focus of intense studies by a number of investigators. More recent work has revisited the role of C/EBPα in normal hematopoiesis, especially its function in HSCs, and also started to provide more mechanistic insights into its role in normal and malignant hematopoiesis. In particular, the differential actions of C/EBPα isoforms, as well as its importance in chromatin modelling and cellular reprogramming, are beginning to be elucidated. Finally, recent work has also shed light on the dichotomous function of C/EBPα in AML by demonstrating its ability to act as both a tumour suppressor and promoter. In the present review, we will summarise the current knowledge on the functions of C/EBPα during normal and malignant hematopoiesis with special emphasis on the recent work.Leukemia accepted article preview online, 25 November 2015. doi:10.1038/leu.2015.324.

Original languageEnglish
JournalLeukemia
Volume30
Pages (from-to)767-775
ISSN0887-6924
DOIs
Publication statusPublished - 2016

ID: 45854816